An Electrocardiogram (ECG) is a test that measures the electrical activity of the heart to identify heart rhythm issues, heart attacks, and other cardiac conditions.

No special preparation is usually required. You may be asked to remove any metal objects or wear a hospital gown for ease of access to the chest area.

You can eat and drink normally before the test. However, avoid consuming large amounts of caffeine or alcohol as they might affect the results.

ECGs are very safe and non-invasive. There are no known risks or side effects associated with the test.

In most cases, you can continue taking your medications as prescribed. However, inform your healthcare provider about any medications you are taking.

It helps diagnose kidney diseases and assesses overall kidney function.

Typically, fasting is not necessary, but inform your healthcare provider about any medications or supplements.

It provides crucial information about kidney health, aiding in diagnosis, treatment, and monitoring of kidney diseases.

Results are usually available within a day, allowing for timely medical decisions based on kidney function assessment.

The target INR range for patients on warfarin therapy varies depending on their condition but is typically between 2.0 and 3.0.

Frequency of testing depends on individual patient needs, but initially, it may be done weekly or bi-weekly until stable, then less frequently thereafter.

Yes, the PT / INR Test can help diagnose various clotting disorders, including those related to liver disease or genetic clotting factor deficiencies.

Medications, dietary changes, liver function, and underlying health conditions can all influence PT / INR results.

Yes, the PT / INR Test is a safe and standard diagnostic procedure used worldwide to monitor blood clotting ability and adjust anticoagulant therapy.